NASDAQ:INFI

Infinity Pharmaceuticals Short Interest Ratio and Short Volume

$2.89
-0.09 (-3.02 %)
(As of 04/19/2021 01:50 PM ET)
Add
Compare
Today's Range
$2.75
Now: $2.89
$2.95
50-Day Range
$2.60
MA: $3.18
$3.64
52-Week Range
$0.78
Now: $2.89
$5.98
Volume26,819 shs
Average Volume3.59 million shs
Market Capitalization$256.17 million
P/E RatioN/A
Dividend YieldN/A
Beta2.4

Short Interest

Infinity Pharmaceuticals (NASDAQ:INFI) Short Interest Data

Current Short Volume1,180,000 shares
Previous Short Volume1,420,000 shares
Change Vs. Previous Month:-16.90%
Dollar Volume Sold Short$3.54 million
Short Interest Ratio / Days to Cover0.3
Last Record DateMarch, 31 2021
Outstanding Shares57,030,000 shares
Percentage of Shares Shorted1.33%
Today's Trading Volume26,819 shares
Average Trading Volume3,593,879 shares
Today's Volume Vs. Average-99.25%

Short Interest Over Time


Infinity Pharmaceuticals (NASDAQ:INFI) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/20211,180,000 shares $3.54 million -16.9%N/A0.3 $3.00
3/15/20211,420,000 shares $4.81 million +14.5%N/A0.4 $3.39
2/26/20211,240,000 shares $3.58 million +115.5%N/A0.3 $2.89
2/12/2021575,400 shares $1.75 million -18.4%N/A0.2 $3.04
1/29/2021705,500 shares $2.79 million +7.5%N/A0.4 $3.95
1/15/2021656,200 shares $2.26 million +19.0%N/A0.5 $3.44
12/31/2020436,100 shares $1.16 million +125.1%N/A0.5 $2.65
12/15/2020436,100 shares $863,478.00 +125.1%N/A0.5 $1.98
11/30/2020193,700 shares $397,085.00 +5.8%N/A0.2 $2.05
11/15/2020183,100 shares $366,200.00 -37.8%N/A0.3 $2.00
10/30/2020294,300 shares $506,196.00 +44.5%N/A0.6 $1.72
10/15/2020203,700 shares $228,144.00 +22.4%0.4%0.4 $1.12
9/30/2020166,400 shares $193,024.00 +112.5%0.3%0.3 $1.16
9/15/202078,300 shares $83,781.00 +1.6%0.1%0.1 $1.07
8/31/202077,100 shares $82,497.00 -48.4%0.1%0.1 $1.07
8/14/2020149,300 shares $164,230.00 +50.8%0.3%0.2 $1.10
7/31/202099,000 shares $120,780.00 +57.1%0.2%0.1 $1.22
7/15/202063,000 shares $56,070.00 +34.9%0.1%0.1 $0.89
6/30/202046,700 shares $38,761.00 -3.9%0.1%0.1 $0.83
6/15/202048,600 shares $43,254.00 +36.1%0.1%0.3 $0.89
5/29/202035,700 shares $31,059.00 +25.3%0.1%0.2 $0.87
5/15/202028,500 shares $25,650.00 -14.4%0.1%0.2 $0.90
4/30/202033,300 shares $31,302.00 -8.0%0.1%0.2 $0.94
4/15/202036,200 shares $36,562.00 -39.4%0.1%0.2 $1.01
3/31/202059,700 shares $63,282.00 +95.7%0.1%0.3 $1.06

Infinity Pharmaceuticals (NASDAQ:INFI) Short Interest FAQ

speech bubbles
speech bubbles











What is Infinity Pharmaceuticals' current short interest?

Short interest is the volume of Infinity Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 1,180,000 shares of INFI short.

Is Infinity Pharmaceuticals' short interest increasing or decreasing?

Infinity Pharmaceuticals saw a decline in short interest during the month of March. As of March 31st, there was short interest totaling 1,180,000 shares, a decline of 16.9% from the previous total of 1,420,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Infinity Pharmaceuticals' short interest compare to its competitors?

0.00% of Infinity Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sub-industry of "biotechnology" compare to Infinity Pharmaceuticals: Amgen Inc. (1.98%), Gilead Sciences, Inc. (1.86%), Vertex Pharmaceuticals Incorporated (0.00%), Regeneron Pharmaceuticals, Inc. (2.16%), Biogen Inc. (2.40%), Alexion Pharmaceuticals, Inc. (3.58%), Seagen Inc. (0.00%), Exact Sciences Co. (0.00%), Incyte Co. (0.00%), and Novavax, Inc. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Analog Devices, Inc. ($5.84 billion), Aon plc ($5.47 billion), Charter Communications, Inc. ($5.36 billion), ViacomCBS Inc. ($3.99 billion), Snap Inc. ($3.77 billion), Airbnb, Inc. ($2.90 billion), Peloton Interactive, Inc. ($2.43 billion), Discovery, Inc. ($2.38 billion), The Kroger Co. ($2.28 billion), and Expedia Group, Inc. ($2.18 billion). View all of the most shorted stocks.

What does it mean to sell short Infinity Pharmaceuticals stock?

Short selling INFI is an investing strategy that aims to generate trading profit from Infinity Pharmaceuticals as its price is falling. Infinity Pharmaceuticals' stock is trading down $0.09 today. To short Infinity Pharmaceuticals stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Infinity Pharmaceuticals will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Infinity Pharmaceuticals?

A short squeeze for Infinity Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of INFI, which in turn drives the price of the stock up even further.

How often is Infinity Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INFI, twice per month. The most recent reporting period available is March, 31 2021.



This page was last updated on 4/19/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.